Evidence map›Paper›PMID 31526432›Full record

ArticleComparative medicine2019

Characterization of a Porcine Model for Von Willebrand Disease Type 1 and 3 Regarding Expression of Angiogenic Mediators in the Nonpregnant Female Reproductive Tract.

Hanna Allerkamp, Stefanie Lehner, Mahnaz Ekhlasi-Hundrieser, Carsten Detering, Christiane Pfarrer, Mario von Depka Prondzinski

Abstract read
In one paragraph

Article in Comparative medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Special considerations in GI bleeding in VWD patients.Hematology. American Society of Hematology. Education Program · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Hanna AllerkampDepartment of Fundamental and Clinical Research, Werlhof Institute, Hannover, Lower Saxony, Germany; Institute of Anatomy, University of Veterinary Medicine Hannover Foundation, Hannover, Lower Saxony, Germany;, Email: hallerkamp@gmail.com.
Stefanie LehnerDepartment of Fundamental and Clinical Research, Werlhof Institute, Hannover, Lower Saxony, Germany.
Mahnaz Ekhlasi-HundrieserDepartment of Fundamental and Clinical Research, Werlhof Institute, Hannover, Lower Saxony, Germany.
Carsten DeteringDepartment of Fundamental and Clinical Research, Werlhof Institute, Hannover, Lower Saxony, Germany.
Christiane PfarrerInstitute of Anatomy, University of Veterinary Medicine Hannover Foundation, Hannover, Lower Saxony, Germany.
Mario von Depka ProndzinskiDepartment of Fundamental and Clinical Research, Werlhof Institute, Hannover, Lower Saxony, Germany.
Werlhof Institute · DEUniversity of Veterinary Medicine Hannover, Foundation · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Von Willebrand disease (VWD), a blood coagulation disorder, is also known to cause angiodysplasia. Hitherto, no animal model has been found with angiodysplasia that can be studied in vivo. In addition, VWD patients tend to have a higher incidence of miscarriages for reasons unknown. Thus, we aimed to examine the influence of von Willebrand factor (VWF) on the female reproductive tract histology and the expression and distribution of angiogenic factors in a porcine model for VWD types 1 and 3. The disease-causing tandem duplication within the

Indexed as

Disease Models, AnimalAngiogenesis Modulating AgentsAnimalsGenotypeHumansPhenotypeReceptor, TIE-1Receptor, TIE-2Swinevon Willebrand Diseasesvon Willebrand FactorAngiogenesis Modulating AgentsReceptor, TIE-1Receptor, TIE-2von Willebrand Factor

Identifiers

PMID31526432
PMCPMC6807720
OpenAlexW2974413306

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.